← Back to Patent Explorer
US3907771A Expired / Lapsed US ⏱️ 0.0 years remaining

Antibiotic 66-40

Assignee: Merck Sharp & Dohme LLC
•
Filing: 1973-06-25
•
Granted: 1975-09-23
•
Expires: 1993-06-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Antibiotic 66-40, a new broad spectrum antibiotic having an adverse effect upon the growth of gram-positive and gram-negative bacteria, is described together with its method of production via the fermentation of Micromonospora inyoensis, a new species of Micromonospora.

Inventors

  • 👤 Marvin J Weinstein
  • 👤 George M Luedemann
  • 👤 Gerald H Wagman

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 01:19
CPC Classifications
C; C07; C07H; C07H15/00; C07H15/20; C07H15/22; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/822; Y10S435/863

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 109 words
A MEMBER SELECTED FROM THE GROUP CONSISTING OF SISOMICIN, NON-TOXIC ACID ADDITION SALTS, INCLUDING SOLVATES THEREOF, AND CONDENSATION PRODUCTS OF SISOMICIN WITHALDEHYDES HAVING UP TO 12 CARBON ATOMS, SAID SISOMICIN BEING A SOLID COMPOSITION OF MATTER HAVING: A. A MOLECULAR WEIGHT OF 447.26 AS DETERMINED BY MASS SPECTROMETRY, B. THE EMPIRICAL FORMULA C19H37N5O7, C. A SPECIFIC OPTICAL ROTATION AS MEASURED BY THE D LINE OF SODIUM AT 26* OF +188.9* IN WATER AT 0.3% CONCENTRATION, D. AN INFRARED ABSORPTION SPECTRUM IN MINERAL OIL SUBSTANTIALLY AS SHOWN IN FIG. 1, AND E. A NUCLEAR MAGNETIC SPECTRUM IN DEUTERIUM OXIDE AS SHOWN IN FIG 2: SAID SISOMICIN HAVING THE FOLLOWING FORMULA:
Claim 2
Dependent Claim 109 words
A MEMBER SELECTED FROM THE GROUP CONSISTING OF SISOMICIN, NON-TOXIC ACID ADDITION SALTS, INCLUDING SOLVATES THEREOF, AND CONDENSATION PRODUCTS OF SISOMICIN WITHALDEHYDES HAVING UP TO 12 CARBON ATOMS, SAID SISOMICIN BEING A SOLID COMPOSITION OF MATTER HAVING: A. A MOLECULAR WEIGHT OF 447.26 AS DETERMINED BY MASS SPECTROMETRY, B. THE EMPIRICAL FORMULA C19H37N5O7, C. A SPECIFIC OPTICAL ROTATION AS MEASURED BY THE D LINE OF SODIUM AT 26* OF +188.9* IN WATER AT 0.3% CONCENTRATION, D. AN INFRARED ABSORPTION SPECTRUM IN MINERAL OIL SUBSTANTIALLY AS SHOWN IN FIG. 1, AND E. A NUCLEAR MAGNETIC SPECTRUM IN DEUTERIUM OXIDE AS SHOWN IN FIG 2: SAID SISOMICIN HAVING THE FOLLOWING FORMULA:
Claim 3
Dependent Claim 16 words
A compound of claim 1, said compound being sisomicin monohydrate in its essentially pure crystalline form.
Claim 4
Dependent Claim 9 words
A compound of claim 1, said compound being sisomicin.
Claim 5
Dependent Claim 15 words
A compound of claim 1, said compound being a nontoxic acid addition salt of sisomicin.
Claim 6
Dependent Claim 10 words
A compound of claim 4, said compound being sisomicin hydrochloride.
Claim 7
Dependent Claim 10 words
A compound of claim 4, said compound being sisomicin sulfate.
Claim 8
Dependent Claim 8 words
A compound of claim 1 of the formula:
Claim 9
Dependent Claim 16 words
A compound of claim 7 wherein R1R2C is a benzylidene radical, said compound having the formula:

References Cited (Backward Citations)

US3651042A Cited
US3753973A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-09-22 1979-03-24 1979-09-23 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-09-22 1983-03-24 1983-09-23 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-09-22 1987-03-24 1987-09-23 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag